Your browser doesn't support javascript.
loading
Investigations of cellular copper metabolism in ovarian cancer cells using a ratiometric fluorescent copper dye.
Mohammed Asiri, Sumayah; Levina, Aviva; New, Elizabeth J; Lay, Peter A.
Afiliação
  • Mohammed Asiri S; School of Chemistry, The University of Sydney, Sydney, NSW, 2006, Australia.
  • Levina A; School of Chemistry, The University of Sydney, Sydney, NSW, 2006, Australia.
  • New EJ; School of Chemistry, The University of Sydney, Sydney, NSW, 2006, Australia. elizabeth.new@sydney.edu.au.
  • Lay PA; The University of Sydney Nano Institute (Sydney Nano), The University of Sydney, Sydney, NSW, 2006, Australia. elizabeth.new@sydney.edu.au.
J Biol Inorg Chem ; 28(1): 43-55, 2023 02.
Article em En | MEDLINE | ID: mdl-36469143
Imbalances in metal homeostasis have been implicated in the progression and drug response of cancer cells. Understanding these changes will enable identification of new treatment regimes and precision medicine approaches to cancer treatment. In particular, there has been considerable interest in the interplay between copper homeostasis and response to platinum-based chemotherapeutic agents. Here, we have studied differences in the Cu uptake and distributions in the ovarian cancer cell line, A2780, and its cisplatin resistant form, A2780.CisR, by measuring total Cu content and the bioavailable Cu pool. Atomic absorption spectroscopy (AAS) revealed a lower total Cu uptake in A2780.CisR compared to A2780 cells. Conversely, live-cell confocal microscopy studies with the ratiometric Cu(I)-sensitive fluorescent dye, InCCu1, revealed higher relative cellular content of labile Cu in A2780.CisR cells compared with A2780 cells. These results demonstrate that Cu trafficking, homeostasis and speciation are different in the Pt-sensitive and resistant cells and may be associated with the predominance of different phenotypes for A2780 (epithelial) and A2780.CisR (mesenchymal) cells.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Antineoplásicos Limite: Female / Humans Idioma: En Revista: J Biol Inorg Chem Assunto da revista: BIOQUIMICA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Austrália

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Antineoplásicos Limite: Female / Humans Idioma: En Revista: J Biol Inorg Chem Assunto da revista: BIOQUIMICA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Austrália